Differences in carbohydrate specificities and complement-activating capacity of guinea pig and human antibodies to neuraminidase-treated autologous erythrocytes
- 1 September 1985
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 22 (9) , 1123-1129
- https://doi.org/10.1016/0161-5890(85)90116-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Deposition of the terminal C5b‐9 complement complex on erythrocytes by human red cell autoantibodiesBritish Journal of Haematology, 1983
- Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.Journal of Clinical Investigation, 1983
- Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.The Journal of Experimental Medicine, 1982
- Complement receptor is an inhibitor of the complement cascade.The Journal of Experimental Medicine, 1981
- Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteThe Journal of Experimental Medicine, 1980
- Nature of Human Serum Blood Group T AntibodiesImmunological Communications, 1979
- Different N-terminal amino acids in the MN-glycoprotein from MM and NN erythrocytesHuman Genetics, 1977
- Human blood-group MN and precursor specificities: structural and biological aspectsCarbohydrate Research, 1975
- THE COMPLEMENT-BINDING AND ABSORPTIVE CAPACITY OF HUMAN WHITE BLOOD CELLS TREATED WITH NEURAMINIDASE1Transplantation, 1972
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serumImmunochemistry, 1966